How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
33
LNTH Quote, Financials, Valuation and Earnings
Last price:
$66.91
Seasonality move
:
34.27%
Day range:
$65.63 - $67.26
52-week range:
$47.25 - $111.29
Dividend yield:
0%
P/E ratio:
28.11x
P/S ratio:
3.06x
P/B ratio:
3.96x
Volume:
668.9K
Avg. volume:
886.4K
1-year change:
-27.88%
Market cap:
$4.4B
Revenue:
$1.5B
EPS (TTM):
$2.38
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LNTH
Lantheus Holdings, Inc.
|
$368M | $1.16 | -6.5% | 18.66% | $83.85 |
|
ALGN
Align Technology, Inc.
|
$1B | $2.96 | 3.53% | 91.22% | $183.87 |
|
COO
The Cooper Cos., Inc.
|
$1B | $1.03 | 6.12% | 98.38% | $91.06 |
|
IART
Integra LifeSciences Holdings Corp.
|
$429.6M | $0.80 | -2.94% | 217.65% | $15.50 |
|
IOVA
Iovance Biotherapeutics, Inc.
|
$82.2M | -$0.17 | 11.5% | -57.01% | $8.35 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$277.2M | -$0.09 | 6.15% | -78.57% | $25.95 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LNTH
Lantheus Holdings, Inc.
|
$66.92 | $83.85 | $4.4B | 28.11x | $0.00 | 0% | 3.06x |
|
ALGN
Align Technology, Inc.
|
$163.03 | $183.87 | $11.7B | 31.59x | $0.00 | 0% | 3.00x |
|
COO
The Cooper Cos., Inc.
|
$81.38 | $91.06 | $15.9B | 43.43x | $0.01 | 0% | 3.98x |
|
IART
Integra LifeSciences Holdings Corp.
|
$11.14 | $15.50 | $867.7M | 70.14x | $0.00 | 0% | 0.52x |
|
IOVA
Iovance Biotherapeutics, Inc.
|
$2.55 | $8.35 | $1B | -- | $0.00 | 0% | 3.38x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$19.89 | $25.95 | $1.3B | -- | $0.00 | 0% | 1.32x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LNTH
Lantheus Holdings, Inc.
|
35.63% | -1.846 | 18.22% | 2.30x |
|
ALGN
Align Technology, Inc.
|
2.97% | 1.016 | 1.34% | 1.08x |
|
COO
The Cooper Cos., Inc.
|
25.25% | -0.120 | 20.32% | 0.89x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | -0.228 | 179.84% | 1.47x |
|
IOVA
Iovance Biotherapeutics, Inc.
|
6.96% | -0.707 | 6.28% | 2.92x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.906 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LNTH
Lantheus Holdings, Inc.
|
$222.4M | $43.6M | 9.52% | 14.66% | 11.36% | $94.7M |
|
ALGN
Align Technology, Inc.
|
$667.1M | $156.1M | 9.43% | 9.72% | 15.67% | $169M |
|
COO
The Cooper Cos., Inc.
|
$601M | $140.4M | 3.45% | 4.56% | 13.18% | $149.9M |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
IOVA
Iovance Biotherapeutics, Inc.
|
$20M | -$89.8M | -50.35% | -54.43% | -133.06% | -$89.5M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
Lantheus Holdings, Inc. vs. Competitors
-
Which has Higher Returns LNTH or ALGN?
Align Technology, Inc. has a net margin of 7.23% compared to Lantheus Holdings, Inc.'s net margin of 5.7%. Lantheus Holdings, Inc.'s return on equity of 14.66% beat Align Technology, Inc.'s return on equity of 9.72%.
Company Gross Margin Earnings Per Share Invested Capital LNTHLantheus Holdings, Inc.57.91% $0.41 $1.7B ALGNAlign Technology, Inc.67% $0.78 $4.1B -
What do Analysts Say About LNTH or ALGN?
Lantheus Holdings, Inc. has a consensus price target of $83.85, signalling upside risk potential of 25.29%. On the other hand Align Technology, Inc. has an analysts' consensus of $183.87 which suggests that it could grow by 12.78%. Given that Lantheus Holdings, Inc. has higher upside potential than Align Technology, Inc., analysts believe Lantheus Holdings, Inc. is more attractive than Align Technology, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNTHLantheus Holdings, Inc.9 2 0 ALGNAlign Technology, Inc.7 8 0 -
Is LNTH or ALGN More Risky?
Lantheus Holdings, Inc. has a beta of -0.076, which suggesting that the stock is 107.602% less volatile than S&P 500. In comparison Align Technology, Inc. has a beta of 1.841, suggesting its more volatile than the S&P 500 by 84.113%.
-
Which is a Better Dividend Stock LNTH or ALGN?
Lantheus Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lantheus Holdings, Inc. pays -- of its earnings as a dividend. Align Technology, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNTH or ALGN?
Lantheus Holdings, Inc. quarterly revenues are $384M, which are smaller than Align Technology, Inc. quarterly revenues of $995.7M. Lantheus Holdings, Inc.'s net income of $27.8M is lower than Align Technology, Inc.'s net income of $56.8M. Notably, Lantheus Holdings, Inc.'s price-to-earnings ratio is 28.11x while Align Technology, Inc.'s PE ratio is 31.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lantheus Holdings, Inc. is 3.06x versus 3.00x for Align Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNTHLantheus Holdings, Inc.3.06x 28.11x $384M $27.8M ALGNAlign Technology, Inc.3.00x 31.59x $995.7M $56.8M
-
Which has Higher Returns LNTH or COO?
The Cooper Cos., Inc. has a net margin of 7.23% compared to Lantheus Holdings, Inc.'s net margin of 7.94%. Lantheus Holdings, Inc.'s return on equity of 14.66% beat The Cooper Cos., Inc.'s return on equity of 4.56%.
Company Gross Margin Earnings Per Share Invested Capital LNTHLantheus Holdings, Inc.57.91% $0.41 $1.7B COOThe Cooper Cos., Inc.56.42% $0.43 $11B -
What do Analysts Say About LNTH or COO?
Lantheus Holdings, Inc. has a consensus price target of $83.85, signalling upside risk potential of 25.29%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $91.06 which suggests that it could grow by 11.9%. Given that Lantheus Holdings, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Lantheus Holdings, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNTHLantheus Holdings, Inc.9 2 0 COOThe Cooper Cos., Inc.7 7 1 -
Is LNTH or COO More Risky?
Lantheus Holdings, Inc. has a beta of -0.076, which suggesting that the stock is 107.602% less volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.033, suggesting its more volatile than the S&P 500 by 3.304%.
-
Which is a Better Dividend Stock LNTH or COO?
Lantheus Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Lantheus Holdings, Inc. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNTH or COO?
Lantheus Holdings, Inc. quarterly revenues are $384M, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. Lantheus Holdings, Inc.'s net income of $27.8M is lower than The Cooper Cos., Inc.'s net income of $84.6M. Notably, Lantheus Holdings, Inc.'s price-to-earnings ratio is 28.11x while The Cooper Cos., Inc.'s PE ratio is 43.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lantheus Holdings, Inc. is 3.06x versus 3.98x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNTHLantheus Holdings, Inc.3.06x 28.11x $384M $27.8M COOThe Cooper Cos., Inc.3.98x 43.43x $1.1B $84.6M
-
Which has Higher Returns LNTH or IART?
Integra LifeSciences Holdings Corp. has a net margin of 7.23% compared to Lantheus Holdings, Inc.'s net margin of -1.34%. Lantheus Holdings, Inc.'s return on equity of 14.66% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital LNTHLantheus Holdings, Inc.57.91% $0.41 $1.7B IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About LNTH or IART?
Lantheus Holdings, Inc. has a consensus price target of $83.85, signalling upside risk potential of 25.29%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 39.14%. Given that Integra LifeSciences Holdings Corp. has higher upside potential than Lantheus Holdings, Inc., analysts believe Integra LifeSciences Holdings Corp. is more attractive than Lantheus Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNTHLantheus Holdings, Inc.9 2 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is LNTH or IART More Risky?
Lantheus Holdings, Inc. has a beta of -0.076, which suggesting that the stock is 107.602% less volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.641%.
-
Which is a Better Dividend Stock LNTH or IART?
Lantheus Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lantheus Holdings, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNTH or IART?
Lantheus Holdings, Inc. quarterly revenues are $384M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. Lantheus Holdings, Inc.'s net income of $27.8M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, Lantheus Holdings, Inc.'s price-to-earnings ratio is 28.11x while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lantheus Holdings, Inc. is 3.06x versus 0.52x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNTHLantheus Holdings, Inc.3.06x 28.11x $384M $27.8M IARTIntegra LifeSciences Holdings Corp.0.52x 70.14x $402.1M -$5.4M
-
Which has Higher Returns LNTH or IOVA?
Iovance Biotherapeutics, Inc. has a net margin of 7.23% compared to Lantheus Holdings, Inc.'s net margin of -135.28%. Lantheus Holdings, Inc.'s return on equity of 14.66% beat Iovance Biotherapeutics, Inc.'s return on equity of -54.43%.
Company Gross Margin Earnings Per Share Invested Capital LNTHLantheus Holdings, Inc.57.91% $0.41 $1.7B IOVAIovance Biotherapeutics, Inc.29.61% -$0.25 $754.8M -
What do Analysts Say About LNTH or IOVA?
Lantheus Holdings, Inc. has a consensus price target of $83.85, signalling upside risk potential of 25.29%. On the other hand Iovance Biotherapeutics, Inc. has an analysts' consensus of $8.35 which suggests that it could grow by 227.45%. Given that Iovance Biotherapeutics, Inc. has higher upside potential than Lantheus Holdings, Inc., analysts believe Iovance Biotherapeutics, Inc. is more attractive than Lantheus Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNTHLantheus Holdings, Inc.9 2 0 IOVAIovance Biotherapeutics, Inc.6 4 1 -
Is LNTH or IOVA More Risky?
Lantheus Holdings, Inc. has a beta of -0.076, which suggesting that the stock is 107.602% less volatile than S&P 500. In comparison Iovance Biotherapeutics, Inc. has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.531%.
-
Which is a Better Dividend Stock LNTH or IOVA?
Lantheus Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iovance Biotherapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lantheus Holdings, Inc. pays -- of its earnings as a dividend. Iovance Biotherapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNTH or IOVA?
Lantheus Holdings, Inc. quarterly revenues are $384M, which are larger than Iovance Biotherapeutics, Inc. quarterly revenues of $67.5M. Lantheus Holdings, Inc.'s net income of $27.8M is higher than Iovance Biotherapeutics, Inc.'s net income of -$91.3M. Notably, Lantheus Holdings, Inc.'s price-to-earnings ratio is 28.11x while Iovance Biotherapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lantheus Holdings, Inc. is 3.06x versus 3.38x for Iovance Biotherapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNTHLantheus Holdings, Inc.3.06x 28.11x $384M $27.8M IOVAIovance Biotherapeutics, Inc.3.38x -- $67.5M -$91.3M
-
Which has Higher Returns LNTH or TNDM?
Tandem Diabetes Care, Inc. has a net margin of 7.23% compared to Lantheus Holdings, Inc.'s net margin of -8.49%. Lantheus Holdings, Inc.'s return on equity of 14.66% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital LNTHLantheus Holdings, Inc.57.91% $0.41 $1.7B TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About LNTH or TNDM?
Lantheus Holdings, Inc. has a consensus price target of $83.85, signalling upside risk potential of 25.29%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $25.95 which suggests that it could grow by 30.48%. Given that Tandem Diabetes Care, Inc. has higher upside potential than Lantheus Holdings, Inc., analysts believe Tandem Diabetes Care, Inc. is more attractive than Lantheus Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNTHLantheus Holdings, Inc.9 2 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is LNTH or TNDM More Risky?
Lantheus Holdings, Inc. has a beta of -0.076, which suggesting that the stock is 107.602% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.683, suggesting its more volatile than the S&P 500 by 68.285%.
-
Which is a Better Dividend Stock LNTH or TNDM?
Lantheus Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lantheus Holdings, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNTH or TNDM?
Lantheus Holdings, Inc. quarterly revenues are $384M, which are larger than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. Lantheus Holdings, Inc.'s net income of $27.8M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, Lantheus Holdings, Inc.'s price-to-earnings ratio is 28.11x while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lantheus Holdings, Inc. is 3.06x versus 1.32x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNTHLantheus Holdings, Inc.3.06x 28.11x $384M $27.8M TNDMTandem Diabetes Care, Inc.1.32x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
40
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Sell
34
PFSI alert for Jan 31
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Sell
40
SHNY alert for Jan 31
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.
